Stage IV prostate cancer: Survival differences in clinical t4, nodal and metastatic disease

Journal of Urology

Volumn 184, Issue 2, 2010, Pages 512-518

  Hsiao, Wayland ^a   Moses, Kelvin A ^a   Goodman, Michael ^b   Jani, Ashesh B ^a,c   Rossi, Peter J ^a,c   Master, Viraj A ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

age groups; neoplasm staging; prostatic neoplasms; SEER program

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; HUMAN; HYPOTHESIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SPOUSE;

AGED; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 77955469824     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.04.010     Document Type: Article

References (20)

1. M.R. Cooperberg, S. Park, and P.R. Carroll Prostate cancer 2004: insights from national disease registries Oncology (Williston Park) 18 2004 1239
2. C. Ahaghotu, A. Baffoe-Bonnie, and R. Kittles Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study Prostate Cancer Prostatic Dis 7 2004 165
3. C.D. Scales Jr, J.W. Moul, and L.H. Curtis Prostate cancer in the Baby Boomer generation: results from CaPSURE Urology 70 2007 1162
4. J.A. Leijte, M. Gallee, and N. Antonini Evaluation of current TNM classification of penile carcinoma J Urol 180 2008 933
5. F.K. Chun, A. Briganti, and T. Lebeau The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy Eur Urol 49 2006 273
6. G.C. Hutterer, and P.I. Karakiewicz Can the AJCC staging system risk-stratify patients with localized prostate cancer? Nat Clin Pract Urol 4 2007 482
7. F. May, R. Hartung, and J. Breul The ability of the American Joint Committee on Cancer staging system to predict progression-free survival after radical prostatectomy BJU Int 88 2001 702
8. M. Roach 3rd, V. Weinberg, and H. Sandler Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score? Cancer 109 2007 213
9. S.H. Taylor, K.W. Merriman, and P.E. Spiess Inadequacies of the current American Joint Committee on Cancer staging system for prostate cancer Cancer 106 2006 559
10. A. Briganti, J.R. Karnes, and L.F. Da Pozzo Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy Eur Urol 55 2009 261
11. P. Guinan, A.K. Stewart, and A.M. Fremgen Patterns of care for metastatic carcinoma of the prostate gland: results of the American College of Surgeons' patient care evaluation study Prostate Cancer Prostatic Dis 1 1998 315
12. M.I. Resnick, and J.T. Grayhack Treatment of stage IV carcinoma of the prostate Urol Clin North Am 2 1975 141
13. P.A. Johnstone, K.C. Ward, and M. Goodman Radical prostatectomy for clinical T4 prostate cancer Cancer 106 2006 2603
14. H. Van Poppel, and S. Joniau An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer Eur Urol 53 2008 253
15. S.A. Boorjian, R.H. Thompson, and S. Siddiqui Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era J Urol 178 2007 864
16. C.W. Cheng, E.J. Bergstralh, and H. Zincke Stage D1 prostate cancer A nonrandomized comparison of conservative treatment options versus radical prostatectomy Cancer 71 1993 996
17. C.K. Gjertson, K.P. Asher, and J.D. Sclar Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era Urology 70 2007 723
18. D. Kroepfl, H. Loewen, and U. Roggenbuck Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy BJU Int 97 2006 985
19. I.J. Powell, C.M. Tangen, and G.J. Miller Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109 J Urol 168 2002 2016
20. B. Shuch, M. Mikhail, and J. Satagopan Racial disparity of epidermal growth factor receptor expression in prostate cancer J Clin Oncol 22 2004 4725